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The goal of this investigation was to determine whether che-
nodeoxycholic acid (CDCA)-induced apoptosis is prevented by
ursodeoxycholic acid (UDCA) or tauroursodeoxycholic acid
(TUDC) and to characterize the involvement of mitochondria in
the process. Cultured human HepG2 cells were treated in a dose-
and time-dependent protocol in order to establish a sufficiently
low exposure to CDCA that causes apoptosis but not necrosis.
Low-dose CDCA induced an S-phase block and G2 arrest of the
cell cycle, as determined by flow cytometry. As a result, cell
proliferation was inhibited. CDCA-induced apoptosis, as deter-
mined by fluorescence microscopy of Hoechst 33342-stained nu-
clei, was evident upon coincubation with TUDC. Additionally,
after exposure to UDCA plus CDCA, the cell membrane was
permeable to fluorescent dyes. Caspase-9-like activity, poly(ADP-
ribose) polymerase (PARP) cleavage, and extensive DNA frag-
mentation were detected in CDCA-exposed cells and in cells
coincubated with TUDC, but not UDCA. CDCA caused a de-
crease in mitochondrial membrane potential and depletion of
ATP, both of which were potentiated by UDCA but not TUDC.
The results suggest that UDCA potentiates CDCA cytotoxicity,
probably at the level of induction of the mitochondrial permeabil-
ity transition (MPT). Consequently, as suggested by the lack of the
main hallmarks of the apoptotic pathway, in the presence of
UDCA, CDCA-induced apoptosis is not properly executed but
degenerates into necrosis.
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bination; apoptosis; necrosis; mitochondria.
Hydrophobic bile acids, such as chenodeoxycholic acid
(CDCA), are implicated as major contributors to cholestatic
liver diseases. Two mechanisms of cell death have been de-
scribed: necrosis at high concentrations of bile acids and apo-
ptosis at lower concentrations (Patel et al., 1994; Spivey et al.,
1993).
Previously, we have demonstrated that CDCA is toxic to
hepatocytes by mechanisms involving mitochondrial dysfunc-
tion (Rolo et al., 2003a). Furthermore, we demonstrated that
ursodeoxycholic acid (UDCA) potentiates CDCA-induced ne-
crosis in primary cultured hepatocytes (Rolo et al., 2003b), by
inducing the mitochondrial permeability transition (MPT).
This adds to the growing controversy regarding the utility of
UDCA in treating cholestatic diseases (Gores et al., 1998;
Krahenbuhl et al., 1994; Rodrigues et al., 1998).
In recent years, considerable research regarding the subject
of cholestasis has focused on the mechanisms by which hy-
drophobic bile acids induce apoptosis, and the putative protec-
tive effect of UDCA. It has been suggested that bile acids
induce cell death via ligand-dependent death receptor path-
ways, especially those involving the Fas receptor (Higuchi et
al., 2001; Miyoshi et al., 1999). Other studies have implicated
oxidative stress and mitochondrial dysfunction in bile acid–
induced apoptosis (Graf et al., 2002; Rodrigues et al., 1998),
specifically through induction of the MPT. Interestingly, hy-
drophobic and potentially toxic bile acids have been found to
also activate survival pathways promoting cell proliferation
(Qiao et al., 2002; Rust et al., 2000). The same survival
pathway (activation of a mitogen-activated protein kinase,
MAPK) has been implicated in protecting against UDCA tox-
icity, since UDCA has been shown to partially activate a
pro-apoptotic cascade (Qiao et al., 2002). It has been previ-
ously observed that UDCA induces apoptosis in hepatocellular
carcinoma cells and potentiates photodynamic therapy (Kessel
et al., 2000; Oyama et al., 2002).
The sum of these observations point to the necessity of
systematic studies to fully understand the mechanisms of bile
acids toxicity and the role of UDCA, either in preventing or
potentiating bile acids toxicity. Toward this goal, we investi-
gated whether CDCA-induced apoptosis is prevented by
UDCA or its taurine-derivative, tauroursodeoxycholic acid
(TUDC), and characterized the involvement of mitochondria in
the process. Due to the interconnection between cell prolifer-
ation and programmed cell death, we also investigated the
effects of bile acids on cell cycle.
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MATERIALS AND METHODS
Materials. The human hepatoma cell line (HepG2) was obtained from
American Type Culture Collection (ATCC, Rockville, MD). UDCA (97%
purity) and CDCA (99% purity) were purchased from Sigma Chemical Co. (St.
Louis, MO). TUDC, as sodium salt (97% purity), was purchased from Cal
Biochem (La Jolla, CA). UDCA was dissolved in ethanol, TUDC and CDCA
in water. Hoechst 33342, sulforhodamine B, and 5-bromo-2-deoxyuridine
(BrdU) were also purchased from Sigma (St. Louis, MO). Tetramethylrho-
damine methyl ester (TMRM) and LIVE/DEAD Viability/Cytotoxicity Assay
Kit were obtained from Molecular Probes (Eugene, OR). The DNA ladder
molecular weight marker was from Promega (Madison, WI) and the BCA
protein assay kit from Pierce Chemical (Rockford, IL). Caspase-9 synthetic
substrate (Ac-LEHD-AFC) and specific inhibitor (Z-Leu-Glu/Ome)-His-
Asp(Ome)-FMK.TFA inhibitor) were purchased from Enzyme Systems (Liv-
ermore, CA).
Purified mouse anti-BrdU and purified mouse anti--tubulin were purchased
from Developmental Studies Hybridoma Bank (Iowa City, IA). Goat-anti-
mouse Texas red was purchased from Jackson ImmunoResearch (West Grove,
PA). Purified mouse anti-cytochrome c (clone 7H8.2C12) and purified mouse
anti-human poly (ADP-ribose) polymerase (PARP, clone 4C10-5) were from
PharMingen International (San Diego, CA). Goat anti-rabbit IgG was from
Jackson ImmunoResearch Laboratories (West Grove, PA).
All other chemicals were of analytical grade and obtained from standard
commercial sources.
Cell culture. HepG2 cells were cultured in Minimum Essential Medium
(MEM) Eagle (with 2 mM L-glutamine and Earle’s BSS adjusted to contain
1.5 g/l sodium bicarbonate, 0.1 mM nonessential amino acids, and 1 mM
sodium pyruvate), containing 10% fetal bovine serum. Cells were maintained
in a humidified CO2 incubator at 37°C and passaged and harvested for
experiments by detachement with 0.05% trypsin and 0.5 mM EDTA in
phosphate-buffered saline (PBS); 80–90% confluent cells were used for bile
acid treatment. Control cultures received an equivalent amount of vehicle
(water or ethanol).
Cell proliferation assay. Cell proliferation was measured with sulforho-
damine B as previously described (Skehan et al., 1990). Briefly, cells were
seeded in 24-well plates at 5  104 cells/ml and allowed to attach and recover
for 1 day prior to drug treatment. After addition of bile acids at the concen-
trations indicated in the legends to the figures, cells were cultured for up to 3
days without media change or drug replenishment. At various time points,
media was removed and the wells rinsed twice with cold PBS. Adherent cells
were fixed with cold 10% trichloracetic acid on ice for 30 min, washed, and
stained with 0.5 % sulforhodamine B. Absorbance of the solubilized dye was
measured at 540 nm in a Shimadzu UV1201 spectrophotometer.
Viability assay. Cell viability was determined by the LIVE/DEAD Via-
bility/Cytotoxicity Assay Kit (Papadopoulos et al., 1994) by flow cytometry.
At 24 or 48 h following exposure to 50 M CDCA and/or 50 M UDCA or
TUDC, cells were harvested by trypsinization and washed twice with PBS.
Cells were resuspended in the working solution of calcein-AM (2 M) and
ethidium homodimer-1 (Eth-D1; 4 M) and incubated for 30 min at 37°C. The
cells were then analyzed with a FACSCalibur flow cytometer (Becton Dick-
inson, San Jose, CA) and CELLQuest software. Approximately 105 cells were
analyzed for each time point and treatment.
Nuclear apoptosis assay. HepG2 cell apoptosis was quantitated by deter-
mining the percentage of cells with nuclear morphologic changes of apoptosis
detected by fluorescence microscopy of Hoechst 33342-stained fixed cells, as
previously described (Holy, 2002). Briefly, cells were seeded on glass cover-
slips in 6-well plates at 5  104 cells/ml. At 24 or 48 h of treatment (50 M
CDCA and/or 50 M UDCA or TUDC), coverslips were fixed and stored in
formaldehyde and stained with 5 mg/ml Hoechst 33342. Coverslips were
inspected and photographed on a Nikon Optiphot epifluorescence microscope
using a Dage MTI SIT-68 video camera (Michigan City, IN). Two hundred and
fifty cells from several randomly chosen fields were counted, and the number
of apoptotic cells was expressed as a percentage of the total number of cells
counted.
Immunocytochemistry. Cells were seeded on glass coverslips in 6-well
plates at 5  104 cells/ml. At 2 or 24 h of treatment (50 M CDCA and/or 50
M UDCA or TUDC), BrdU (5-bromo-2-deoxyuridine) labeling solution
(final concentration 10 M in culture medium) was added and incubated for
3 h at 37°C. BrdU, a thymidine analogue, is a specific S-phase marker
(Gratzner, 1982). Cells were then fixed and stored in cold (–10°C) absolute
methanol. At 24 and 48 h of treatment (50 M CDCA and/or 50 M UDCA
or TUDC), cells for labeling with antibodies to -tubulin were also fixed. The
procedure was essentially as previously described (Pierce et al., 1999). Cov-
erslips used for comparison of immunolabeling intensities between control and
treated groups were all processed together and photographed at the same
exposure times under identical conditions.
Cell cycle analysis. Cell cycle analysis based on DNA content was per-
formed as follows. At 24 h, following exposure to experimental treatments (50
M CDCA and/or 50 M UDCA or TUDC), cells were harvested by
trypsinization and washed twice with PBS. Cells were then suspended in PBS,
and 100 l of RNase (1 mg/ml) and 100 l of propidium iodide (100 mg/ml)
were added to the cell suspensions and incubated at 37°C for 30 min. The cells
were then analyzed with a FACSCalibur flow cytometer (Becton Dickinson,
San Jose, CA) and ModFit cell cycle analysis software. Approximately 105
cells were analyzed for each time point and treatment.
Detection of cytochrome c release in cells. To quantify cytochrome c
release, immunoblot analysis of cytochrome c in the mitochondria and the
cytosolic fractions were performed (Gottlieb and Granville, 2002). Briefly, at
48 h following exposure to experimental treatments (50 M CDCA and/or 50
M UDCA or TUDC), HepG2 cells were trypsinized, washed, and resus-
pended in 100 l of ice-cold buffer (250 mM sucrose, 20 mM HEPES KOH
(pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 1 mM
PMSF, 1 g/ml aprotinin, and 1 g/ml leupeptin). After 30 min incubation on
ice, cells were homogenized with a glass Dounce homogenizer. The protein
concentration in the cytosolic and mitochondrial fractions, upon separation by
centrifugation, was detected using the BCA protein assay kit. Equal amounts
of protein were resuspended in SDS–PAGE buffer and boiled in a water bath
for 5 min. Lysates were stored at –80°C until further analysis. Proteins were
separated under reducing conditions for 2 h at 120 V, as previously described
(Pierce et al., 1999).
Analysis of poly (ADP-ribose) polymerase cleavage. Poly (ADP-ribose)
polymerase (PARP) cleavage was detected by Western blot. Briefly, at the end
of treatment (48 h of exposure to 50 M CDCA and/or 50 M UDCA or
TUDC), cells were collected by trypsinization and washed with PBS. The final
cell pellet was resuspended in an approximately equal volume of Tris-buffered
saline (TBS). A threefold volume of SDS sample buffer (6% sodium dodecyl
sulfate, 5% b-mercaptoethanol, 0.01% bromophenol blue in 40% glycerol) was
added and the mixture boiled for 10 min. The boiled sample was passed
through a 28-gauge syringe multiple times to shear the DNA and stored at
–80°C until assayed, as previously described (Pierce et al., 1999).
Measurement of cellular caspase-9 activity. Caspase-9 activity was quan-
tified by measuring cleavage of a fluorometric peptide Ac-LEHD-AFC.
Briefly, at the end of designated treatments (48 h of exposure to 50 M CDCA
and/or 50 M UDCA or TUDC), cells were harvested and washed with PBS,
and equal numbers of control or treated cells were lysed in cell lysis buffer (10
mM Tris–HCl, pH 7.5, 10 mM NaH2PO4, 130 mM NaCl, 1% Triton X-100,
and 10 mM NaPPi). The cell lysate was then incubated at 37°C with Ac-
LEHD-AFC (10 g/ml). After 2 h incubation, substrate cleavage leading to the
release of the fluorescent AFC moiety (excitation 390 nm, emission 510 nm)
was monitored by a Labsystems type 374 plate-reader. For blocking experi-
ments, cell lysate was preincubated with caspase-9 specific inhibitor (Z-Leu-
Glu/Ome-His-Asp(Ome)-FMK.TFA inhibitor) (10 g/ml), prior to the addi-
tion of synthetic substrates. Changes in caspase activity were expressed as
percent change from control, which was set as 100%.
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Agarose electrophoresis for DNA fragmentation. Cells (1  106) col-
lected after treatments (48 h of exposure to 50 M CDCA and/or 50 M
UDCA or TUDC) were washed in ice-cold PBS and resuspended in 450 ml
digestion buffer (100 mM NaCl, 10 mM Tris–HCl, pH 8, 25 mM EDTA, 0.5%
SDS, 0.1 mg/ml proteinase K). RNase (final concentration 20 g/ml) was then
added, and incubation was continued at 37°C for 1 h. After incubation (50°C)
overnight for complete digestion, DNA was extracted with an equal volume of
phenol/chloroform/isoamyl alcohol and precipitated with ethanol. DNA frag-
mentation was detected by electrophoresis in 1.5% agarose gel containing 1
g/ml ethidium bromide; 100-bp ladder molecular weight markers were used.
Measurement of mitochondrial membrane potential. To monitor mito-
chondrial transmembrane potential (), HepG2 cells were loaded with 6.6
M tetramethylrhodamine methyl ester (TMRM) in culture media, as previ-
ously described (Rolo et al., 2003b). The different additions are shown in the
legends to the figures.
Determination of ATP content. The extraction of ATP from cells was
performed as previously described (Ryll and Wagner, 1991), after 48 h
incubation of HepG2 cells in culture with the compounds (50 M CDCA
and/or 50 M UDCA or TUDC). ATP was quantitated by HPLC as previously
described (Stocchi et al., 1985) and the concentration expressed per million
viable cells as determined by Trypan blue exclusion.
Statistical analysis. Solvent controls (water or ethanol) were included
within each experimental determination, and the numerical data are expressed
as a percentage of the respective control (mean  SEM, for 3–4 independent
experiments). Ethanol itself had no effect on any of the parameters measured.
Statistical significance was determined by the one-way ANOVA Student-
Newman-Keuls post-t-test for multiple comparisons. A p value  0.05 was
considered statistically significant.
RESULTS
Effects on Cell Proliferation
In this work, cell proliferation was assessed as a fundamen-
tal parameter to determine time- and dose- dependent effects of
bile acids (Fig. 1). Concentrations of 25, 50, 75, and 100 M
CDCA were evaluated for periods of 24, 48, and 72 h. Expo-
sure of HepG2 cells to 25 M CDCA had no effect on cell
proliferation (data not shown). However, exposure to 50 M
CDCA for 24 h (data not shown) resulted in inhibition of cell
proliferation that was even more pronounced at 48 h (Fig. 1).
Since no cells were detached (an initial indicator of acute cell
damage), we concluded that inhibition of cell proliferation was
due to a specific effect of CDCA on cell division. A similar
effect was observed at later time points (72 h) and at higher
concentrations (75 and 100 M) of CDCA (data not shown).
Time- (24, 48 and 72 h) and dose- (25, 50, 75, and 100 M)
response studies for UDCA and TUDC revealed that these bile
acids by themselves did not have any effect on HepG2 cell
proliferation in culture (Fig. 1). However, upon coincubation
with CDCA (50 M) plus UDCA (50 M) for 48 h, inhibition
of cell proliferation was potentiated (Fig. 1). TUDC (50 M)
did not alter CDCA effects on cell proliferation.
Effects on Cell Viability
The next set of experiments was designed to confirm that, at
the concentrations selected, bile acids did not elicit any alter-
ation on plasma membrane integrity, which is an indicator of
necrotic cell death. Based on the results of the first set of
experiments, 50 M CDCA, UDCA, and TUDC were selected
as the concentrations for use in these studies. Following expo-
sure to 50 M of bile acids for 48 h, cells were stained with a
combination of calcein-AM and ethidium homodimer and an-
alyzed by flow cytometry.
At 24 h, no membrane alterations were observed (data not
shown). However, at 48-h exposure to CDCA, there was a
decrease in calcein-AM and an enhancement of Eth-D1 fluo-
rescence (Fig. 2), indicating an increase in plasma membrane
permeability. This was not surprising since it is known that, at
late stages of apoptosis, plasma membrane becomes perme-
able. UDCA or TUDC (50 M ) alone had no effect (Fig. 2).
However, UDCA potentiated the changes caused by CDCA,
suggesting an extensive population of damaged cells (Fig. 2).
TUDC did not alter the toxicity caused by CDCA (Fig. 2).
FIG. 1. Effects of bile acids (50 M CDCA and/or 50 M UDCA or 50
M TUDC) on cell proliferation at 48 h. Cell proliferation was measured with
sulforhodamine B. Percent proliferation was calculated by comparing with
control cell proliferation, considered as 100% at each time point. Data repre-
sent the mean  SEM of measurements of four separate experiments. Values
that share the same letter are not statistically different (p  0.05).
FIG. 2. Effects of bile acids on cell viability, based on retention of
calcein-AM and ethidium homodimer in HepG2 cells, analyzed by flow
cytometry. Cells were treated with 50 M CDCA and/or 50 M UDCA or 50
M TUDC for 48 h. Alterations in probe retention were determined by flow
cytometry. Percent probe retention was calculated by comparing with control
probe retention, considered as 100%. Data represent the mean  SEM of four
separate experiments. Values that share the same letter are not statistically
different (p  0.05).
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Effects on Cell Cycle
Cell cycle effects of CDCA were investigated in a series of
experiments using the same protocol but two different assays
(flow cytometry and microscopy). After 24-h exposure to the
different compounds, cells were harvested and cell cycle ana-
lyzed (Figs. 3A and 3B). This time point was chosen because
we have previously observed an inhibition of cell proliferation
without changes in cell viability.
Exposure to CDCA for 24 h caused a marked decrease in the
number of cells in S phase, suggesting an S-phase block and
G2 arrest (Fig. 3A). UDCA and TUDC by themselves had no
effect on cell cycle, nor did they alter cell cycle response to
CDCA (Fig. 3A).
We performed an additional study to evaluate DNA synthe-
sis, measuring bromodeoxyuridine (BrdU) incorporation (Fig.
3B, lower panel). Less then 1% of cells treated with 50 M
CDCA for 24 h incorporate BrdU. The 24-h exposure was
compared with an earlier short (2 h) exposure to establish a
time-dependent effect. We conclude that CDCA at 24 h in-
duced cell growth inhibition through induction of cell cycle
arrest, because no significant apoptosis is evident in these cell
cultures as shown in Figure 3B (upper panel) with cells labeled
with Hoechst 33342.
Effects on Chromatin Condensation and Tubulin
Organization
In the sequence of the results described, we evaluated DNA
changes by Hoechst 33342 staining following cell exposure to
the different compounds for 48 h. Since apoptotic cells un-
dergo a marked change in morphology, we also assessed al-
terations in tubulin organization, a component of the cytoskel-
eton.
A study of the nuclear changes, by staining with Hoechst
33342 dye, demonstrated that 50 M CDCA induced nuclear
changes typical of apoptosis in 40% of the cells by 48 h (Figs.
4A and 4B). Disorganization of tubulin was also observed (Fig.
4A).
The percentage of apoptotic nuclei upon combined exposure
to both CDCA and TUDC did not differ from that in CDCA-
treated cells (Fig. 4B). In contrast, treatment with 50 M
UDCA plus 50 M CDCA resulted in fewer apoptotic nuclei
(Fig. 4A). Taking into account the previous results in which a
FIG. 3. (A) Effects on cell cycle of HepG2 cells by flow cytometry. Cells
were treated with 50 M CDCA and/or 50 M UDCA or 50 M TUDC for
24 h. Data represent the mean  SEM of three separate measurements. Values
that share the same letter are not statistically different (p  0.05). (B)
Micrographs showing cells treated for 2 h and 24 h with 50 M CDCA. Cells
were double-labeled with Hoechst 33342 for DNA (upper panel) and antibody
to BrdU (lower panel).
FIG. 4. (Top) Micrographs showing cells treated with 50 M CDCA
and/or 50 M UDCA for 48 h. Cells were double-labeled with Hoechst 33342
for DNA (upper panel) and antibody to tubulin (lower panel). Arrows indicate
apoptotic nuclei. (Bottom) Percentage apoptosis as determined by Hoechst
33342 staining. Cells were treated with 50 M CDCA and/or 50 M UDCA
or 50 M TUDC for 48 h. Percent apoptosis was obtained by comparing with
control cell apoptosis, considered as 100% at time 0. Data represent the mean
 SEM of three separate experiments. Values that share the same letter are not
statistically different (p  0.05).
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rapid loss of plasma membrane integrity was observed under
the same experimental conditions (Fig. 2), we propose that the
decreased apoptosis indicates that these cells underwent necro-
sis. UDCA and TUDC by themselves did not stimulate apo-
ptosis (Figs. 4A and 4B).
Effects on DNA Fragmentation
DNA fragmentation was used as another criterion to distin-
guish between apoptosis and necrosis. Consistent with the
previous nuclear changes, cells treated with 50 M CDCA or
50 M CDCA plus 50 M TUDC for 48 h started to show
DNA fragmentation (Fig. 5). In UDCA plus CDCA–treated
cells, on the other hand there was no cleavage of DNA that
could be detected by gel electrophoresis (Fig. 5). No DNA
fragmentation was observed in cells treated with UDCA or
TUDC alone. These results further support a prominent role for
necrotic cell death upon exposure to the combination UDCA
plus CDCA, although apoptotic nuclei were observed with
Hoechst 33342 staining.
Effects on Poly (ADP-Ribose) Polymerase (PARP)
We next assessed cleavage of the caspase-3 substrate PARP,
another feature of apoptosis. Cleavage of PARP was observed
in cells exposed to CDCA and TUDC plus CDCA, but not any
other conditions (Fig. 6). The absence of PARP cleavage in
cells exposed to CDCA plus UDCA further suggested that
UDCA potentiates CDCA cytotoxicity through necrotic, rather
then apoptotic cell death.
Effects on Caspase-9 Activity
To determine whether mitochondria were involved in the
observed apoptosis caused by CDCA, we evaluated caspase-9
activity. Figure 7 presents the effects of bile acids on activated
caspase-9 activity. Fluorescence due to the release of the
fluorescent AFC moiety upon cleavage of the peptide Ac-
LEHD-AFC by caspase-9 increased dramatically in cells
treated with CDCA or CDCA plus TUDC. The general
caspase-9 specific inhibitor (Z-Leu-Glu/Ome)-His-Asp(Ome)-
FMK.TFA inhibitor) prevented such increase in fluorescence.
Although UDCA by itself did not change caspase-9 activity, it
substantially inhibited caspase activation caused by CDCA
(Fig. 7).
Effects on Cytochrome c Release
Release of cytochrome c is a key event in regulating
caspase-3 activation by the apoptosome complex. We next
assessed cytochrome c release in treated cells (Fig. 8). Cyto-
chrome c release was detected after 24-h exposure to CDCA
alone and in combination with UDCA or TUDC (data not
shown), followed by a more marked release after 48 h. Indeed,
upon 48-h treatment with 50 M CDCA, results clearly dem-
onstrate cytochrome c distribution in the cytoplasm in addition
to mitochondrial localization, although mitochondrial fraction
contained a considerably lower amount (Fig. 8). On the other
FIG. 5. Pattern of DNA fragmentation in HepG2 cells. Cells were incu-
bated with 50 M CDCA and/or 50 M UDCA, TUDC for 48 h. DNA
fragmentation was assayed on 1.5% agarose gels. Lane Mw, marker; lane 1,
control; lane 2, UDCA; lane 3, TUDC; lane 4, CDCA; lane 5, CDCA 
UDCA; lane 6, CDCA  TUDC.
FIG. 6. The cleavage of caspase-3 substrate, PARP, during cell death.
Cells were incubated with 50 M CDCA and/or 50 M UDCA or TUDC for
48 h. PARP cleavage was analyzed by Western blot. Lane 1, control; lane 2,
CDCA; lane 3, UDCA; lane 4, TUDC; lane 5, CDCA UDCA; lane 6, CDCA
 TUDC.
FIG. 7. Caspase-9 activation in HepG2 cells. Cells were incubated with 50
M CDCA and/or 50 M UDCA or TUDC for 48 h. Data represent the mean
 SEM of three separate experiments. Values that share the same letter are not
statistically different (p  0.05).
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hand, in cells exposed to CDCA plus UDCA, cytochrome c
was confined to the cytosolic fraction (Fig. 8). Coincubation
with CDCA and TUDC did not affect the pattern of cyto-
chrome c distribution as compared to cells incubated with
CDCA alone (data not shown). After 48-h exposure to UDCA
(Fig. 8) or TUDC, HepG2 cells retained cytochrome c in the
mitochondrial fraction.
Effects on Mitochondrial Membrane Potential
To further analyze mitochondrial role in the process, we
evaluated mitochondrial membrane potential () upon addi-
tion of bile acids (4 h) to cell suspensions. As shown in Figure
9, CDCA addition to HepG2 cells in suspension resulted in a
decrease of TMRM retention (50%). UDCA by itself induced
15% depolarization. CDCA plus UDCA caused more substan-
tial mitochondrial depolarization, when compared with CDCA
alone. Cyclosporin A (CyA), a potent inhibitor of the mito-
chondrial permeability transition, prevented both CDCA and
UDCA plus CDCA–induced depolarization of mitochondrial
membrane potential (Fig. 9). Compared to cytochrome c re-
lease, which was observed upon 48 h of exposure to the
compounds, mitochondrial depolarization occurs much earlier
and before the release of cytochrome c.
Effects on ATP Content
In the previous reports, we have shown that exposure of
cultured rat hepatocytes to bile acids results in decreased
cellular ATP, which may reflect cell death due to bioenergetic
failure (Rolo et al., 2003b). The development of apoptosis
requires ATP; a substantial loss of ATP contributes to inhibi-
tion of caspases (Eguchi et al., 1999). We questioned whether
maintenance of a critical ATP content is needed to prevent
breakdown of the plasma membrane in CDCA-treated cells.
Alternatively, cells exposed to the combination CDCA plus
UDCA would have a premature demise to necrotic cell death
due to ATP depletion. To pursue this, intracellular ATP content
was measured in cells exposed to the bile acids for 48 h. As
shown in Figure 10, exposure to CDCA caused a 25% decrease
in cell ATP. Furthermore, coincubation with CDCA plus
UDCA resulted in a dramatic 80% reduction in cellular ATP
content. Addition of TUDC to CDCA-treated cells did not alter
the effect of CDCA on cell ATP. UDCA and TUDC, alone, did
not affect cell ATP.
DISCUSSION
Apoptotic cell death induced by bile acids has emerged as an
important mechanism underlying bile acid–induced hepatotox-
icity. In this study, CDCA-induced apoptosis was associated
with an initial block of S phase, the cell cycle phase in which
cells are most sensitive to inhibitors of DNA synthesis. Inhi-
bition of cell proliferation by conjugated and unconjugated bile
FIG. 8. Cytochrome c release in HepG2 cells. Cells were incubated with
50 M CDCA and/or 50 M UDCA for 48 h. Cytochrome c release was
analyzed by Western blot. Lane 1, control; lane 2, CDCA; lane 3, UDCA; lane
4, CDCA  UDCA.
FIG. 9. Mitochondrial depolarization induced by bile acids (50 M
CDCA and/or 50 M UDCA). In some experiments, cells were supplemented
with 1 M CyA. The change in  induced by the test agents was expressed
as percent  in the absence of bile acids, taking into account the complete
depolarization of mitochondrial membrane potential by FCCP. Data represent
the mean  SEM of three different measurements. Values that share the same
letter are not statistically different (p  0.05).
FIG. 10. Measurement of cellular ATP content after bile acids exposure.
Cells were cultured in a glucose-free medium supplemented with 2 mM
pyruvate and incubated with 50 M CDCA and/or 50 M UDCA or 50 M
TUDC for 48 h. Adenine nucleotides were determined by HPLC. Using this
method, content for control cells was 82.5  2.3 nmol/million cells. Data are
expressed as percent content compared to untreated cells. Data represent the
mean SE of three separate experiments. Values that share the same letter are
not statistically different (p  0.05).
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acids was also observed in rat hepatocytes in primary culture
(Martinez-Diez et al., 2000). The mechanism underlying
CDCA inhibition of S phase was not addressed in this work. It
is known that cell cycle regulators, such as p53, play an
important role in the process of apoptosis (Kastan et al., 1995).
Since HepG2 cells have a wild-type p53, this might be one of
the factors modulating the sensitivity to CDCA (Bressac et al.,
1990).
Numerous studies have demonstrated that cells undergoing
apoptosis exhibit a decrease in mitochondrial membrane po-
tential, preceding nuclear signs of apoptosis (Ferri and Kro-
emer, 2001), suggesting that early alterations of mitochondrial
function may be important for initiating the apoptotic process.
Our results demonstrate the activation of the mitochondrial
apoptotic pathway in a hepatoma cell line following CDCA
exposure, involving MPT induction. Such an event was shown
by the early depolarization of mitochondrial membrane poten-
tial that is inhibited by CyA. In fact, impairment of mitochon-
drial function has been previously demonstrated to be a key
mechanism by which bile acids cause cell dysfunction (Kra-
henbuhl et al., 1994; Rolo et al., 2000, 2003b). Cytochrome c
release and caspase-9 activation, with subsequent PARP cleav-
age and nuclear condensation, followed the onset of MPT by
CDCA. It is well known that activated caspase-9 triggers a
cascade that culminates in the activation of caspase-3, which
cleaves several substrates, resulting in chromosomal DNA
fragmentation and cellular morphologic changes characteristic
of apoptosis (Cai et al., 1998). Activation of caspase-9 usually
occurs downstream of cytochrome c release from mitochondria
and may be preceded by mitochondrial translocation of Bax
(Narita et al., 1998). A previous study by Rodrigues and
coworkers, reported that deoxycholic acid–induced apoptosis
in primary rat hepatocytes was associated with decreased mi-
tochondrial transmembrane potential and increased mitochon-
dria-associated Bax protein (Rodrigues et al., 1999). Indeed,
Bax activation has been proposed as an integrator of diverse
pro- and anti-apoptotic signals, cell fate being decided by the
resultant release of cytochrome c (Brenner and Kroemer,
2000). This would explain the role for the Fas pathway as a
common mechanism by which cytotoxic bile acids also induce
apoptosis (Sodeman et al., 2000), which was not evaluated in
the present work. Interestingly, a recent work by Schoemaker
and coworkers (Schoemaker et al., 2003) has shown that the
glycine derivative of CDCA induces apoptosis in a mitochon-
dria-controlled pathway in which caspase-8 is activated in a
FADD-independent manner. Therefore, apoptotic pathways are
differentially activated by the distinct bile acids.
From this study, UDCA potentiates MPT induction in
HepG2 cells by CDCA, as previously shown in isolated mito-
chondria (Rolo et al., 2000). The ability of UDCA to enhance
mitochondrial membrane depolarization, sensitive to CyA, was
associated with a much greater loss of ATP. Apoptotic changes
in CDCA-treated cells occurred without a massive disruption
of the plasma membrane as indicated by calcein-AM retention,
Eth-D1 exclusion, and ATP loss. Thus, it appears that apopto-
sis is activated at low CDCA concentration and occurs after a
long time of exposure, when compared with the combined bile
acid cytotoxicity. Interestingly, cells exposed to UDCA alone
underwent only a slight decrease in mitochondrial membrane
potential with no significant change in ATP content, suggesting
that cytotoxicity induced by UDCA is only expressed when
CDCA is present. Such an effect may occur by potentiation of
MPT induction. One explanation for this difference could be
that induction of the MPT in a small fraction of mitochondria
could activate the apoptotic process, whereas induction of
mitochondrial transition in a large portion of mitochondria
could cause bioenergetic collapse, as shown by ATP depletion,
beyond which apoptosis could not proceed, leading to necrosis.
Previously, we have shown that CDCA plus UDCA induces a
decrease in mitochondrial respiration and activates the mito-
chondrial permeability transition (Rolo et al., 2000, 2003b),
resulting in a bioenergetic failure, with cell death showing
necrotic characteristics (Rolo et al., 2003b). These changes
occurred over a rapid time course (4 h) and following exposure
to higher concentrations of bile acids (Rolo et al., 2003b).
It has been proposed that caspase inactivation in lethally
injured cells switches the mode of cell death from apoptosis to
necrosis (Lemaire et al., 1998). Although cytochrome c release
in CDCA plus UDCA–treated cells was evident, no caspase
activity was observed. Such results suggest that ATP depletion
plays a key role in caspase inactivation and loss of plasma
membrane integrity. It may also explain the inhibition of other
typical features of apoptosis in cells exposed to CDCA plus
UDCA.
It is clear that bile acids, although at higher concentrations
than used in this work, stimulate the generation of reactive
oxygen species in isolated rat hepatocytes, primary cultured
hepatocytes, and purified hepatocyte mitochondria (Rodrigues
et al., 1998; Sokol et al., 1995). Yerushalmi and collaborators
reported that, in glycochenodeoxycholic acid–induced apopto-
sis, oxidative stress was a key mediator of the mitochondrial
permeability transition (Yerushalmi et al., 2001). We do not
exclude the oxidation of cysteine residues in caspases as the
mechanism responsible for their inactivation.
The role of UDCA in hepatic apoptosis is controversial. On
one hand, UDCA has been described as decreasing apoptosis
induced by deoxycholic acid and tumor growth factor- in both
hepatic and nonhepatic cells (Rodrigues et al., 1998, 1999).
The probable mechanism was suggested to be via modulation
of mitochondrial function and membrane stability, although a
role of alteration of the bile acid pool was not ruled out
(Rodrigues et al., 1998). Other authors have described poten-
tiation of cell dysfunction induced by UDCA. UDCA induces
apoptosis in hepatocellular carcinoma cells, mediated by in-
creased levels of Bax in mitochondria and cytochrome c in the
cytosol (Oyama et al., 2002). Preincubation of murine leuke-
mia and hepatoma cells with UDCA potentiated the effects of
photodynamic therapy (Kessel et al., 2000). Such action in-
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volved effects at the level of mitochondrial depolarization,
release of cytochrome c into the cytosol, and activation of
caspase-3. Glyco- and tauro-conjugates of UDCA displayed
the same action (Kessel et al., 2000). In contrast, TUDC
proved to be effective in reducing both GCDC-induced apo-
ptosis and cytolysis (Benz et al., 1998). The condition that
UDCA exerts such an effect, if present before but not upon
irradiation (Kessel et al., 2000), supports our suggestion that
UDCA per se does not cause mitochondrial membrane damage
but lowers the threshold for the action of other compounds.
Another interesting finding was the observation that UDCA
activates a pro-apoptotic cascade, which is generally inhibited
by a simultaneous and stronger activation of the MAPK sur-
vival pathway (Qiao et al., 2002). These discrepant results may
also be dependent on the different characteristics of the cell
culture and the different expression of regulatory proteins. For
example, S-adenosylmethionine has been described as an anti-
apoptotic agent in cultured rat hepatocytes but pro-apoptotic in
human hepatoma cells (Ansorena et al., 2002).
Interestingly, besides a key regulatory role in signal trans-
duction pathways, anti-apoptotic properties attributed to
TUDC have been associated with potent mitochondrial mem-
brane-stabilizing effects, preventing the binding of Bax to the
outer mitochondrial membrane (Rodrigues et al., 2001). How-
ever, previous studies with the goal to characterize the com-
mon apoptotic signaling pathways in human hepatoma cells
have shown that p53 and c-Myc play a more important role in
the apoptotic signaling pathway in HepG2 cells than the Bcl-2
gene family (Jiang et al., 1996). Therefore, the lack of effect of
TUDC in CDCA-induced apoptosis may be the result of acti-
vation of different apoptotic pathways. However, since the
hepatoblastoma cell line HepG2 is unable to take up bile acids
via sodium-dependent pathways (the main system for the up-
take of conjugated bile acids) because Ntcp is not expressed
(Boyer et al., 1993), this may also be the explanation for
TUDC behavior in this model. Sodium-independent hepatocel-
lular uptake of bile salts is mediated by several members of the
OATP family of membrane transporters, which are multispe-
cific transporters that mediate hepatocellular uptake of a vast
variety of other amphipathic organic compounds in HepG2
cells.
TUDC is the taurine conjugate of UDCA, and differential
effects on the induction of apoptosis may be a consequence of
the altered physical-chemical properties. For example, amida-
tion is known to significantly reduce the cytotoxicity of the
more lipophilic forms of unconjugated bile acids, both in
hepatocytes (Scholmerich et al, 1984) and bile duct cells.
Sarbu and coworkers (2001) published on the lipophilic char-
acter of bile acids and their tauro-conjugates and showed that
the main difference between these compounds is their polarity
and acidity. Tauro-conjugates are more polar and acidic and,
thereby, substantially less lipophilic than unconjugated bile
acids, which appear to be important determinants of cytotox-
icity.
In summary, the results of this study demonstrate that acti-
vation of apoptosis by CDCA involves an early loss of mito-
chondrial membrane potential. Cytochrome c release and acti-
vation of the caspase cascade probably follow this initial event.
Coincubation with UDCA appears to induce necrosis as the
predominant form of cell death, by a mechanism that involves
extensive mitochondrial dysfunction. In view of this, although
CDCA, by itself and at low concentrations, is an inducer of
apoptosis, UDCA potentiates CDCA cell toxicity not by in-
creasing apoptosis, but by diverging to necrotic pathways.
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